Jesús
San Miguel Izquierdo
Consultor Investigador
Lund University
Lund, SueciaPublicaciones en colaboración con investigadores/as de Lund University (4)
2017
-
Second primary malignancies in multiple myeloma: An overview and IMWG consensus
Annals of Oncology, Vol. 28, Núm. 2, pp. 228-245
2014
-
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
American Journal of Hematology, Vol. 89, Núm. 4, pp. 355-362
2008
-
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Leukemia, Vol. 22, Núm. 2, pp. 414-423
2003
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group
British Journal of Haematology, Vol. 121, Núm. 5, pp. 749-757